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Enhanced photodynamic therapy and
fluorescence imaging using gold nanorods for
porphyrin delivery in a novel in vitro squamous
cell carcinoma 3D model†
Fatma Demir Duman, *ad Matej Sebek,bc Nguyẽ̂n T. K. Thanh, bc
Marilena Loizidou,a Kaveh Shakiba and Alexander J. MacRobert*a
Nanocomposites of gold nanorods (Au NRs) with the cationic porphyrin TMPyP (5,10,15,20-tetrakis(1-
methyl 4-pyridinio)porphyrin tetra(p-toluenesulfonate)) were investigated as a nanocarrier system for
photodynamic therapy (PDT) and fluorescence imaging. To confer biocompatibility and facilitate the
cellular uptake, the NRs were encapsulated with polyacrylic acid (PAA) and efficiently loaded with the
cationic porphyrin by electrostatic interaction. The nanocomposites were tested with and without light
exposure following incubation in 2D monolayer cultures and a 3D compressed collagen construct of
head and neck squamous cell carcinoma (HNSCC). The results showed that Au NRs enhance the
absorption and emission intensity of TMPyP and improve its photodynamic efficiency and fluorescence
imaging capability in both 2D cultures and 3D cancer constructs. Au NRs are promising theranostic
agents for delivery of photosensitisers for HNSCC treatment and imaging.
1. Introduction
Head and neck cancers comprise a group of heterogeneous
tumours located in various anatomical sites of the head and
neck region. About 90% of these cancer types display squamous
cell carcinoma histology.1,2 Each year, 500 000 people are
diagnosed with head and neck squamous cell carcinoma
(HNSCC). This corresponds to the sixth most common cancer
across the world, of which 40–50% results in death.3,4 This
tumour type comprises neoplasms of the oral and nasal cavity,
larynx and pharynx, and exhibits a heterogeneous and complex
anatomical structure.5 The established standard treatment
modalities are surgery and/or radiation therapy, combined with
chemotherapy.6,7 However, ablative surgery often requires
removal of functional tissues to ensure tumour-free margins
that affect body functions including speech and swallowing.
On the other hand, radiotherapy can induce major adverse
events such as osteoradionecrosis, difficulty in speech and
swallowing.8 Thus, there is a necessity to develop curative
treatment techniques with no long-term side effects.
Photodynamic therapy (PDT) is a promising alternative
treatment for precancerous and cancerous oral lesions with
its minimal cumulative side effects. Its non-invasive nature has
enabled the application of the technique successfully for
HNSCC treatment with no adverse effects.8–11 PDT uses a
photosensitizer (PS), low power, non-thermal visible light and
molecular oxygen. The photosensitizer is activated upon
absorption of light, which results in the generation of reactive
oxygen species (ROS) such as singlet oxygen that induce cellular
damage by oxidizing substrates such as aromatic amino acids
and membrane components such as unsaturated fatty acid and
cholesterol. For eradication of malignant, premalignant or
hyperproliferative lesions, direct cellular and vascular destruc-
tion and activation of the host immune response can contri-
bute to the mechanism of eradication.12–15
The use of metallic nanoparticles to enhance the photo-
dynamic activity of photosensitizers by increasing singlet oxy-
gen generation has stimulated considerable interest.16,17 Under
light excitation, surface electrons of metallic nanoparticles
show a collective oscillation (localized surface plasmon) that
can stimulate various optical events near the surface of metallic
nanoparticles such as metal enhanced singlet oxygen generation,
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surface-enhanced Raman scattering (SERS), absorption, and
fluorescence and phosphorescence emission intensity.18,19
Gold nanorods (Au NRs) have attracted attention due to their
high biocompatibility, stability and tunable plasmon resonance
bands that enhance ROS generation for PDT applications.20–23
Ferreira and coworkers investigated gold nanostructures of
spheres and rods, loading them with a photosensitizer,
5,10,15,20-tetrakis(N-methylpyridinium-4-yl)porphyrin tosylate
salt, to form colloidal hybrid systems. Their studies using
electron paramagnetic resonance (EPR) showed that the hybrid
systems composed of Au NRs and the photosensitizer are more
efficient than their free structures in terms of ROS generation,
although this was not the case for spheroidal NPs.23
The therapeutic efficacy of anticancer agents has to date
generally been assessed in 2 dimensional (2D) monolayer
in vitro cell culture or in vivo animal models.24 However, 2D
models cannot replicate interactions between the cells and the
surrounding extracellular matrix (ECM) that are present with
in vivo models, and the main interactions of the cells in the
monolayer culture take place with the plastic surface.25,26 On
the other hand, in vivo models are expensive and time-
consuming, which can decelerate the screening of new drugs
and approval of new treatments. Animal studies are also
subject to an increasing focus with the principles of the ‘3Rs’
(Replacement, Reduction and Refinement), which has led to
the search for alternative approaches.26 In order to overcome
these problems, researchers have developed in vitro 3D culture
models that mimic the microenvironmental structure of
in vivo solid tumour, and bridge the gap between in vitro 2D
findings and in vivo relevance.27,28 3D models incorporate ECM
materials such as collagen that forms a scaffold for 3D cellular
organization and in vivo interactions. This structure provides a
biomimetic tumour model that can recapitulate some in vivo
properties such as cell differentiation, proliferation, gene and
protein expression, and enable better screening for drug
discovery.29 A further key advantage that is particularly relevant
to an oxygen-dependent therapy like PDT is that 3D models can
incorporate the hypoxia that is often observed in solid tumours.
For nanoparticle testing, 3D models also hold great promise for
assessment of their therapeutic and imaging abilities including
PDT particularly since they can accommodate the slower
diffusion of nanoparticles through ECM compared to small
molecular photosensitisers.29–31 In this regard, compressed
collagen hydrogel constructs, as employed herein, exhibit near
physiological collagen densities of ca. 10% wt/wt compared to
o0.5% wt/wt of standard uncompressed hydrogels.32
In the present work, we initially synthesized Au NRs with
seed-mediated growth in the presence of a cationic surfactant,
cetyltrimethylammonium bromide (CTAB), and then after
coating Au NRs with an anionic polymer, polyacrylic acid
(PAA), we decorated them with a positively charged, water-
soluble PS, 5,10,15,20-tetrakis(1-methyl 4-pyridinio)porphyrin
tetra(p-toluenesulfonate) (TMPyP). Porphyrins are excellent PSs
with high molar absorption coefficients in the visible region, high
quantum yields of the triplet state and long-lived excited states
(1 s), low dark toxicity and fluorescence imaging properties.33,34
TMPyP has a high 1O2 yield (fD = 0.77) and ROS generation
ability upon light activation, which results primarily in DNA
damage35 and changes in cytoskeleton dynamics that cause
microtubule disorganization and depolymerization by its abil-
ity to bind tubulin.36 The photodynamic effect of TMPyP has
been shown by many groups against various human cancer cell
lines including ovary,37 colon,38,39 lungs,37 cervix,36,40
breast,37,41 leukemia,35 melanoma,36,41 and larynx.42 This PS
has also been investigated for other biomedical applications
including sensing, detection and imaging.43–46
The prepared structures were characterized by using absor-
bance and fluorescence spectroscopy, transmission electron
microscopy (TEM), dynamic light scattering (DLS) and zeta
potential analysis. The dark toxicity and PDT effects were
compared with Au NRs without PAA coating and free TMPyP
in 2D monolayer cancer models and 3D compressed collagen
constructs of A431 human squamous carcinoma. The hybrid
structures were also evaluated as optical cancer imaging agents
owing to the emission of TMPyP in the red and near-infrared
regions of the optical spectrum.
2. Materials and methods
2.1 Materials
The following products were used as received. Gold(III) chloride
trihydrate (HAuCl43H2O, Z99.9% trace metal basis), sodium
borohydride (NaBH4, 98%), sodium bromide (NaBr, Z99.0%),
sodium chloride (NaCl, Z99.5%), L-ascorbic acid (99%), silver
nitrate (AgNO3, 0.1 N), hydrogen chloride (HCl, 37 wt% in
water), poly(acrylic acid, sodium salt) solution (PAA, average
MW B15 000, 35 wt% in water), 5,10,15,20-tetrakis(1-methyl
4-pyridinio)porphyrin tetra(p-toluenesulfonate) (TMPyP), thia-
zolyl blue tetrazolium bromide (MTT, 98%), bovine serum
albumin, Tritont X-100, phosphate buffered saline (PBS),
Dulbecco’s phosphate-buffered saline (modified, without
calcium chloride and magnesium chloride, liquid) and 96-well
plates (Cornings TC-treated, clear, polystyrene, flat bottom) were
purchased from Sigma-Aldrich (UK). CTAB (498%) was
obtained from Tokyo Chemical Industry (TCI, Japan). Minimum
essential medium (MEM (10, no glutamine), 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES) buffer solution (1 M),
penicillin–streptomycin and trypsin-ethylenediaminetetraacetic
acid (trypsin-EDTA) (1, 0.25%) were purchased from Gibco
(UK). MEM with Earle’s Balanced Salt Solution (EBSS, without
L-glutamine) was provided by Fisher Scientific Ltd (UK). Rat tail
collagen (Type I) was purchased from First Link Ltd (Cat #: 60-30-
810, UK). Alexa Fluort 488 Phalloidin and AlamarBlue
cell viability reagent were purchased from Invitrogen (UK).
VECTASHIELDs antifade mounting medium with 40,6-diamidino-
2-phenylindole (DAPI) was obtained from Vector Labs (UK).
Black 96-well plates (polypropylene, F-bottom, chimney) were
purchased from Greiner Bio-One International (UK). Glass
bottomed tissue culture dishes (Fluorodish Cell Culture Dish –
35 mm) were purchased from World Precision Instruments (UK).
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Ultra-pure water (18.2 MO cm) was used in all experiments
(Milli-Q Integral 5 system, Merck Millipore, USA).
2.2 Synthesis of AuNRs
Au NRs were synthesized via the seed-mediated method according
to the previous reports with slight modifications.47,48
Synthesis of Au seeds. The reaction was performed at 25 1C.
5 mL of a solution of HAuCl4 (1 mM) was added to the
completely dissolved CTAB solution (5 mL, 0.2 M). 0.8 mL of
ice-cold NaBH4 (10 mM) was added at once into this mixture
under vigorous stirring. The solution was stirred for 30 s and
kept undisturbed for 1 h at 25 1C. Then, the seed solution was
immediately used for gold nanorod synthesis.
Synthesis of Au NRs. 205 mL of AgNO3 (4 mM) was added into
5 mL of completely dissolved CTAB solution (0.1 M) and kept
undisturbed for 15 min at 25 1C. HAuCl4 (5 mL, 1 mM), NaBr
(396 mL, 0.52 M) and HCl (12 mL, 37%) were subsequently
introduced into this mixture, respectively, and stirred slowly.
The mixture was vigorously stirred for 30 s after addition of
75 mL of ascorbic acid (79 mM). Finally, 60 mL of the seed
solution was added into the growth solution at once and 30 s
vigorous stirring was performed one more time. The solution
was left undisturbed at 25 1C overnight (12–16 h). The Au NRs
were washed by centrifugation twice at 8500 rpm for 15 min
and the pellet was re-suspended in 4 mL of deionized water for
further studies.
2.3 PAA coating of Au NRs
The Au NRs were then electrostatically coated with PAA polymer
(B15 kDa MW) at 25 1C. PAA solution (100 mL, 10 mg mL1
prepared in 10 mM NaCl solution) and NaCl solution (100 mL,
10 mM) were simultaneously added to 1 mL of Au NR solution
(1.12 mg mL1). The solution was stirred gently for 30 min to
achieve complete polymer coating. To remove excess PAA, the
resulting solution was centrifuged for 3 min at 14 000 rpm (1)
and the pellet was re-suspended in deionized water.49
2.4 Cationic porphyrin loading of PAA-Au NRs
A 0.47 mg mL1 aqueous solution of PAA-Au NRs was mixed
with the cationic porphyrin TMPyP at different concentrations
and stirred for 15 min at room temperature for electrostatic
binding of the porphyrin with the NRs.
2.5 Characterization methods
Absorbance and fluorescence measurements were recorded
using a Spectramax M2/M2e UV/Vis/NIR spectrophotometer.
The hydrodynamic size and z potential of the particles were
determined with a Malvern Zetasizer Nano-Z. TEM images were
obtained using a JEM-2100 microscope operating at 200 kV.
Aqueous solutions of Au NRs were dropped on a carbon-coated
Cu-grid and dried for TEM imaging analysis. pH measurements
were performed using an Orion Star A111 Benchtop meter from
Thermo Scientific. Fluorescence spectroscopic measurements
in cells were performed using a fluorescence plate reader
(Fluoroskan Ascent, Thermo Labsystems).
2.6 Cell culture
A431 human squamous carcinoma cells were purchased from
Sigma (# 85090402) and were cultured in MEM supplemented
with 10% FBS, 1% penicillin–streptomycin (10 000 units per ml
and 10 000 mg ml1, respectively), 2 mM glutamine and 1% non-
essential amino acid solution, and grown in a humidified
incubator at 37 1C under 5% CO2.
2.7 In vitro dark toxicity and phototoxicity studies on 2D
monolayer HNSCC models
Dark toxicity. A431 cells were seeded at a density of 7500
cells per well into 96-well plates and incubated at 37 1C in a
5% CO2 atmosphere. On the second day, the cells were treated
with Au NRs, PAA-Au NRs, PAA-Au NR + TMPyP and free
cationic porphyrin TMPyP in different concentrations in
serum-free medium and incubated for an additional 24 h at
37 1C in a 5% CO2 atmosphere. On the third day, the culture
medium in each well was replaced with serum-containing
medium without NR and TMPyP photosensitizer, and incu-
bated for another 24 h. On the fourth day, the cytotoxicity was
measured by MTT assay. 25 mL of MTT solution (5 mg mL1 in
PBS) was added to each well with 75 mL of culture medium and
incubated for 4 more hours. DMSO/EtOH (1 : 1 v/v) solution was
used to dissolve purple formazan crystals that appear in the
mitochondria of the living cells and the absorbance intensity
was measured at 570 nm using a microplate reader (Fluoroskan
Ascent, Thermo Labsystems). The percent cell viability was
calculated in reference to the untreated control cells using
the following formula:
Cell viability %ð Þ ¼ sample absorbance
control absorbance
 
 100 ðn ¼ 5Þ (1)
PDT phototoxicity. A431 cells were seeded and treated with
samples as in the dark toxicity studies. On the third day, after
replacement of the medium, the plates were illuminated with
light for up to 10 min using a blue LumiSources flatbed lamp
with peak emission at 420 nm and 7 mW cm2 output (PCI
Biotech, Oslo, Norway). The illuminated cells were incubated
for an additional 24 h at 37 1C in 5% CO2 and cell viability
was assessed by MTT assay on the fourth day as described
previously. The cells without treatment with samples were
considered as controls. The untreated control cells without
sample were also studied with and without light exposure.
2.8 Fluorescence measurements on 2D monolayer HNSCC
models
Fluorescence detection of the nanocomposites of Au NRs,
PAA-Au NRs, PAA-Au NR + TMPyP and free cationic porphyrin
TMPyP treated 2D monolayer A431 cancer models was per-
formed using an inverted fluorescence microscope and a
fluorescence plate reader. To prepare 2D monolayer A431
cancer models for fluorescence imaging, on the first day,
A431 cells were seeded at a density of 150 000 cells in a glass
bottom tissue culture dish and incubated for 24 h under
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standard culture conditions. On the second day, they were
incubated with the samples at 20 mg mL1 NRs and 1.08 mg mL1
equivalent TMPyP concentration of PAA-Au NRs + TMPyP in serum-
free medium. After 24 h of incubation with the samples, 2D
monolayer models were washed with PBS, fixed with formalin for
20 min at room temperature, stained with DAPI nuclei dye for
10 min (2 mg mL1), and finally left in 1 mL of PBS to keep the cells
from air drying. The fixed cells were visualized using an inverted
fluorescence microscope (Olympus BX63; Olympus, Tokyo, Japan)
using filters for DAPI (Ex/Em = 360/460 nm) and TMPyP (Cy5: Exc/
Em = 620/700 nm), respectively.
For a quantitative measurement of the fluorescence inten-
sity by using a fluorescence plate reader, A431 cells were seeded
at a density of 7500 cells per well into 96-well plates and
incubated for 24 h under standard culture conditions. The
samples were then incubated with the cells at different con-
centrations in serum-free medium and incubated for 24 h. On
the third day, the cells in each well were washed with PBS (3),
left in 0.2 mL of PBS, and then the fluorescence intensities were
recorded between 600 and 750 nm using a fluorescence plate
reader (Fluoroskan Ascent, Thermo Labsystems) and excitation
at 420 nm.
2.9 Manufacture of 3D compressed HNSCC collagen
constructs
The 3D compressed collagen constructs of A431 human squa-
mous carcinoma were prepared using RAFT 3D culture systems
following the manufacturer’s instructions (Lonza, Slough, UK)
and the procedure of Hadi et al.32,50,51 In brief, 10% 10 MEM
(employed as colour/pH indicator) and 80% Rat Tail Collagen
Type I were mixed and neutralized using a solution prepared
from 1.65 M NaOH and 840 mM HEPES buffer solution for
hydrogel formation. A431 cells were seeded into this collagen
hydrogel structure at a density of 50 000 cells and the obtained
collagen-MEM-cell solution was aliquoted into the 96-well plate
(240 mL per well) after being mixed gently. The constructs were
incubated under standard culture conditions for 15 min to
initiate collagen fibrillogenesis and produce a cell-populated
collagen hydrogel. The collagen constructs were subjected to
plastic compression using hydrophilic RAFTt absorbers placed
on the hydrogels and left for 15 min at room temperature.
Finally, the absorbers were removed and the cells were returned
to the incubator at 37 1C under 5% CO2, after addition of fresh
culture medium to each well.
2.10 Imaging of 3D compressed HNSCC collagen constructs
Cell morphology and spheroid formation in 3D cancer con-
structs were investigated at different time points (days 1, 3, 7
and 10) using Alexa Fluort 488 Phalloidin staining to visualize
filamentous actin, and DAPI dye for imaging of cell nuclei
following initial cell seeding. To prepare the constructs for
imaging, they were fixed with 10% formalin for 30 min and
washed with PBS. Then, they were permeabilised with 1%
bovine serum albumin (BSA) and 0.3% Triton X solution for
1 h, stained with Phalloidin (2.5% in BSA/Triton-X solution) for
1.5 h and washed with PBS (3). The constructs were placed on
a slide and treated with one drop of VECTASHIELDs antifade
mounting medium with DAPI and covered with a cover slip. Then,
they were imaged using an Olympus BX63 inverted fluorescence
microscope equipped with filters for DAPI (Exc/Em = 360/460 nm)
and Alexa Fluor 488 labelled Phalloidin (Exc/Em = 495/525 nm),
respectively.
2.11 In vitro dark toxicity and PDT phototoxicity studies on
3D compressed HNSCC collagen constructs
The early model of 3D compressed collagen constructs pre-
pared by RAFTt 3D culture systems (1 day growth) were
incubated with Au NRs, PAA-Au NRs, PAA-Au NRs + TMPyP
and free TMPyP at 20 mg mL1 NRs, 1.08 mg mL1 equivalent
TMPyP concentration of PAA-Au NRs + TMPyP in serum-free
medium for 24 h. On the next day, the medium of each
construct was replaced with serum-containing medium without
NRs and photosensitizer. To assess the dark toxicity of the
samples in the 3D compressed collagen constructs of A431, the
3D structures were directly returned to the incubator for
another 24 h of incubation. To assess the PDT effect of TMPyP
loaded PAA-Au NRs, the constructs were illuminated with a blue
LumiSources flatbed lamp with peak emission at 420 nm and
7 mW cm2 output (PCI Biotech, Oslo, Norway) for 7 min and
20 min and then returned to the incubator. After 24 h, both
dark toxicity and phototoxicity of 3D constructs were evaluated
by Alamar Blue assay according to the manufacturer’s instruc-
tions. Alamar Blue solution was added to each well as 10% of
the culture medium and incubated at 37 1C in 5% CO2 for 4 h.
Then, the supernatant in each well was transferred into 96-well
black plates. Fluorescence measurements were recorded under
560 nm excitation and 590 nm emission using a fluorescence
plate reader (Fluoroskan Ascent, Thermo Labsystems). The
constructs without treatment with the samples were used
as controls. The percentage cell viability was calculated by
comparing the fluorescence intensities of each construct to
the fluorescence in the untreated cells.
2.12 Imaging of 3D compressed HNSCC collagen constructs
using cationic porphyrin loaded Au NRs
The fluorescence images of Au NRs, PAA-Au NRs, PAA-Au NRs +
TMPyP and free TMPyP treated 3D compressed head and neck
squamous cancer collagen constructs were recorded using
an inverted fluorescence microscope. The early models of
3D compressed collagen constructs were incubated with the
samples at 20 mg mL1 NRs, 1.08 mg mL1 TMPyP concentration
and incubated for a further 24 h at 37 1C in 5% CO2. Afterwards,
3D constructs were washed with PBS (3), fixed with 10%
formalin (30 min), and permeabilised with 1% BSA and 0.3%
Triton X solution (1 h). They were washed with PBS (3)
between each step. The constructs were placed on a slide
and covered with a cover slip after placing one drop of
VECTASHIELDs antifade mounting medium containing DAPI.
The prepared constructs were imaged using an Olympus BX63
inverted fluorescence microscope equipped with filters
for DAPI (Ex/Em = 360/460 nm) and TMPyP (Cy5: Exc/Em =
649/670 nm), respectively.
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2.13 Statistical analysis
Statistical evaluation of data was carried out using one-way
analysis of variance (ANOVA) followed by post hoc Tukey’s
Multiple Comparison Test, using Graph Pad Prism software
program version 6. Only a p-value o0.05 was considered as
statistically significant. All quantitative data were presented as
mean values  standard deviation (SD).
3. Results and discussion
Au NRs are capable of delivering high payloads of therapeutic
agents with their large surface area-to-volume ratio.52–54 A
higher uptake of the NRs in tumour compared to adjacent
normal tissue is facilitated by the enhanced permeability and
retention (EPR) effect. Therefore, Au NRs are applicable to the
focal treatment of cancer including photodynamic and/or
photothermal therapy.55 In this study, we loaded Au NRs with
a cationic photosensitizer, TMPyP, to increase the photody-
namic effect of the photosensitizer and use the hybrid struc-
tures as cancer imaging agents on 2D monolayer and 3D
compressed collagen constructs of HNSCC, which is one of
the most common cancers worldwide.
3.1 Preparation of cationic porphyrin loaded Au NRs
In this study, Au NRs were synthesized using seed-mediated
growth in two steps. In the first step (seed), the seeds were
prepared in a cationic surfactant CTAB dissolved aqueous
solution. In the second step (growth), these seeds were added
to a solution including CTAB in which more HAuCl4 is reduced
by L-ascorbic acid. CTAB added in the growth step achieves the
direct growth of the seeds along one axis forming rods.47,48,56
Au NRs show two characteristic bands in the absorption
spectrum (Fig. 1A). The lower peak at 511 nm represents the
surface plasmon resonance along the transverse direction. The
second dominant peak at 818 nm originates from the surface
plasmon along the longitudinal direction. As observed in TEM
pictures in Fig. S1A (ESI†), the average rod dimensions are
29.6  8.1 nm in length and 6.4  1.4 nm in width. However,
CTAB is a well-known toxic cationic surfactant and Au NRs
prepared by CTAB demonstrate toxicity.57 To reduce the cyto-
toxicity of CTAB and facilitate the cellular uptake of Au NRs, we
coated Au NRs with anionic PAA by layer-by-layer adsorption, as
shown in Scheme 1.49 After coating, the zeta potential of the Au
NRs changed from a positive charge (45.6  3.4 mV) to a highly
negative charge (56.4  0.6 mV) with an increase in their
hydrodynamic size from 39.2  0.6 nm to 54.0  1.5 nm
(Table 1) and with no change in surface plasmon resonance
peaks (Fig. 1A). The hydrodynamic diameter measured by DLS
of rod-like Au NRs is not precise since a spherical model is used
to calculate the data. Nonetheless, it is still useful to demon-
strate the tendency of size change of the nanorods before and
after any surface modification.58–61 The TEM image presented
in Fig. S1B (ESI†) showed that PAA coating did not seem to
make the rods aggregate.
The prepared PAA-Au NRs were then loaded with a cationic
photosensitizer, TMPyP, by the layer-by-layer technique
(Scheme 1). The anionic surface of PAA-Au NRs was electro-
statically coated with TMPyP at different concentrations of
0.0125–0.050 mg mL1 to find the optimal loading of the
photosensitizer. The results indicated that the decoration of
PAA-Au NRs with TMPyP increases both their hydrodynamic
size and surface charge (Table 1). The increase in hydro-
dynamic diameter in water is probably a result of the aggrega-
tion of the particles through p to p stacking and hydrophobic
interactions as a result of the increased concentration of
porphyrin-based photosynthesizer TMPyP on the nanorod
structures. Gong et al. reported that since porphyrin structures
have hydrophobic pyrrole subunits, hydrophobic interactions
and p to p interaction between adjacent porphyrin macrocycles
will be the dominant factors leading to nanoparticle aggrega-
tion in aqueous solution in spite of substitution to the
Fig. 1 Spectroscopic evaluation of Au NRs, PAA-Au NRs, PAA-Au NRs + TMPyP and free TMPyP in aqueous solutions. Normalized absorbance (A) and
normalized emission spectra (B). The numbers in the parentheses imply mg mL1 TMPyP concentration used for the loading. The concentration of PAA-
Au NR is fixed to 0.47 mg mL1 in the TMPyP loaded PAA-Au NR solutions. The concentration of the naked Au NR solution is 0.26 mg mL1, that of PAA-
Au NR is 0.70 mg mL1, and that of free TMPyP is 0.1 mg mL1 (lexc = 420 nm).
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porphyrin structure.62 This effect has been reported in other
studies, where incorporation of the photosynthesizer to the
particles causes an increase in hydrodynamic size not only due
to the volume of the photosynthesizer but also due to the
increased aggregation of the particles under aqueous condi-
tions as a result of the interactions of the pyrrole subunits.63–65
These factors imply an efficient interaction between anionic
PAA-Au NRs and the cationic photosensitizer TMPyP. However,
the zeta potential remained quite stable at the 0.025 mg mL1
concentration of TMPyP while the hydrodynamic size contin-
ued to increase. To keep the size minimum for biomedical
applications, we decided to use the TMPyP concentration of
0.025 mg mL1 in PAA-Au NR solution having a 0.47 mg mL1
nanorod concentration.
The absorption spectrum of a typical porphyrin consists of a
strong peak at about 400 nm (Soret band), followed by several
weaker absorptions (Q band) at higher wavelengths (at about
515, 585 and 640 nm). As shown in Fig. 1A, the TMPyP loaded
PAA-Au NRs show these characteristic peaks that confirm the
successful incorporation of the photosensitizer with PAA-Au
NRs. In addition, porphyrins possess red or near-infrared
fluorescence under excitation of visible light, which allows
the diagnostic fluorescence imaging applications by visualiza-
tion of intracellular localization of photosensitizers, and makes
them favourable theranostic agent besides the photodynamic
therapy.66,67 TMPyP loaded PAA-Au NRs maintain the charac-
teristic emission peaks of the photosensitizer, as seen from the
emission spectra of PAA-Au NRs loaded with TMPyP in different
concentrations (Fig. 1B), while Au NRs and PAA-Au NRs do not
show any fluorescence, hence they have no signal (lexc =
420 nm). This highlights their possible applications as fluores-
cence imaging agents.
3.2 In vitro dark toxicity and phototoxicity studies on 2D
monolayer HNSCC models
To understand the dark toxicities and PDT effects of the
prepared Au NRs, PAA-Au NRs, TMPyP loaded PAA-Au NRs
(PAA-Au NRs + TMPyP) and free TMPyP, they were incubated
on 2D in vitro monolayer models of A431 HNSCC without
irradiation conditions. As shown in Fig. 2A, Au NRs possess
high cytotoxicity even at the lowest concentrations due to CTAB
coating. CTAB is a cationic surfactant that can enter cells
with or without Au NRs, damage mitochondria, and induce
apoptosis.68 To overcome this problem, we coated the Au NR
surface with an anionic biocompatible polymer, PAA. As shown
in the graph, the surface chemistry has a dominant role in the
cytotoxicity. The cell viability increased dramatically after the
incorporation of PAA as a surface coating as well as function-
alizing the surfaces of NRs for further applications as it allowed
here the loading of photosensitizer TMPyP electrostatically.
Free TMPyP and PAA-Au NRs + TMPyP do not exhibit any
significant dark cytotoxicity. This shows that they do not have
Table 1 Hydrodynamic diameters reported as intensity average and
corresponding polydispersity index (PDI) and zeta potential values of Au
NRs, PAA-Au NRs, PAA-Au NRs + TMPyP and free TMPyP in aqueous
solutions. The numbers in the parentheses imply mg mL1 TMPyP concen-
tration used for the loading
Sample Size (nm) PDI
Zeta potential
(mV)
Au NRs 39.2  0.6 0.534  0.003 45.6  3.4
PAA-Au NRs 54.0  1.5 0.540  0.035 56.4  0.6
PAA-Au + TMPyP (0.0125) 111.8  4.3 0.578  0.051 48.9  4.1
PAA-Au + TMPyP (0.025) 113.1  2.4 0.261  0.007 10.6  1.3
PAA-Au + TMPyP (0.0375) 148.1  1.9 0.117  0.013 10.6  0.1
PAA-Au + TMPyP (0.050) 358.3  8.7 0.214  0.015 7.5  0.4
Scheme 1 Preparation of photosensitizer loaded PAA coated Au NRs and their application as a PDT agent in a 3D hydrogel model consisting of A431
cancer cells surrounded by a type 1 rat tail collagen matrix under irradiation with light. (A) Au NRs synthesized by seed-mediated growth. (B) PAA-Au NRs
prepared by PAA coating of Au NRs in 10 mM NaCl solution. (C) TMPyP loading of PAA-Au NRs under aqueous conditions electrostatically. (D) Irradiation
of the 3D compressed collagen constructs of A431 human squamous carcinoma incubated with PAA-Au NRs + TMPyP with blue light and ROS
generation. (E) Irradiation of the 3D constructs by orange light and fluorescence imaging.
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any significant intrinsic toxicity (i.e., dark toxicity) without light
irradiation during administration.
To evaluate the PDT potential of the samples, the in vitro 2D
monolayer A431 cells incubated with the components were illu-
minated using a blue LumiSources flatbed lamp at 420 nm and
7 mW cm2 output for 5 min, 7 min and 10 min. To understand
the effect of light illumination on cell growth, cells without any
sample treatment were illuminated under the same conditions
and their cell viability was compared with that of the non-
illuminated cells. As can be seen in Fig. S2 (ESI†), the light
illumination does not have any effect on the cell viability. The
results represented in Fig. 2 indicate that use of Au NRs as a
carrier system enhances the photodynamic effect of the photo-
sensitizer. In particular, at 5 min illumination, the difference
between the therapeutic effect of PAA-Au NRs + TMPyP and free
TMPyP is clearly evident. This effect can be due to the enhanced
localized electric field surrounding Au NRs, hence inducing an
increase in light absorption of the photosensitizers and in singlet
oxygen formation via energy transfer from the excited photosen-
sitizer to molecular oxygen.23 At longer illumination times, the
cytotoxic effect of free TMPyP is more apparent. Another impor-
tant point is that naked Au NRs and PAA-Au NRs also exhibited
phototoxicity with light illumination as compared to their
dark toxicity (Fig. S4, ESI†). This effect of Au NRs is due to
their ROS generation under light irradiation like organic dye
photosensitizers.23 Similar effects were reported with Au NRs
embedded with a photosensitizing dye (crystal violet) in a
polyurethane matrix to create ROS, with bactericidal activity.69
Here, all contributions of Au NRs to ROS formation enhanced
the therapeutic effects of pure TMPyP, resulting in a synergistic
effect.
3.3 Fluorescence measurements on 2D monolayer HNSCC
models
The metal-free bases of porphyrins exhibit intense fluorescence
from 600–750 nm for which deeper tissue penetration of light
occurs. In addition, porphyrins can selectively accumulate in
tumour tissues to a higher extent than in the surrounding
healthy tissues, and be retained there for long periods of
time.70 This makes them suitable agents for tumour detection
and imaging.
To evaluate the optical imaging potential of TMPyP loaded
PAA-Au NRs, 2D monolayer A431 cells were incubated with Au,
PAA-Au, PAA-Au + TMPyP NRs at 20 mg mL1 and equivalent
free TMPyP (1.08 mg mL1) for 24 h and the fluorescence
emission intensities were recorded at 600–750 nm under
420 nm excitation after the cells were washed with PBS to
Fig. 3 Fluorescence spectra of 2D monolayer HNSCC models incubated
with Au NRs, PAA-Au NRs, TMPyP, PAA-Au NRs + TMPyP NRs at 20 mg mL1
and equivalent free TMPyP (1.08 mg mL1) for 24 h (lexc = 420 nm).
Fig. 2 Dark toxicity and phototoxicities of Au, PAA-Au, TMPyP loaded PAA-Au NRs and free TMPyP on in vitro 2D monolayer HNSCC models measured
by MTT assay. (A) Dark toxicities at 48 h incubation. (B) Cell viability under light illumination with a blue LumiSources flatbed lamp at 420 nm and
7 mW cm2 output for 5 min, (C) 7 min, and (D) 10 min at 24 h incubation and additional 24 h incubation post illumination.
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remove uninternalised samples. As can be seen in Fig. 3, Au
and PAA-Au NR treated cells do not demonstrate any significant
fluorescence feature while cationic porphyrin TMPyP has
an obvious emission at 650–750 nm. However, after TMPyP
loading, PAA-Au NRs show very strong emission intensity,
which is significantly enhanced compared to the fluorescence
of free TMPyP in aqueous solution at the equivalent concen-
tration. The concentration dependent fluorescence intensities
of the samples in 2D monolayer A431 cells are presented in
Fig. S3 (ESI†). This is probably a result of the increased
light absorption of TMPyP with enhanced localized electric
field surrounding Au NRs and as a result of this event,
higher emission output,16,23,71,72 hence more triplet state and
more singlet oxygen generation via the Type 2 process, as
seen in the phototoxicity studies shown in Fig. 2.73–76 This
synergistic effect seen between NRs and the photosensitizer
allows their application in optical fluorescence imaging of deep
tissues.
3.4 Manufacture of 3D compressed HNSCC constructs and
phototoxicity studies
In vitro 2D cell culture and in vivo models have been the main
platforms to test materials, especially in drug discovery.24 Easy
preparation, maintanance and monitoring of 2D cell cultures
make them the most applied techniques. However, growing the
cells on a flat surface as monolayers without any vital interac-
tions between the cells and surrounding extracellular matrix,
and limited cell-to-cell interactions can prevent obtaining real
results that can be found in vivo.
The ECM consists of many structural proteins; predomi-
nantly, type 1 collagen fibrils is the main constituent of in vivo
connective tissues and solid tumours.77–79 Therefore, 3D models
Fig. 4 Fluorescence microscopy images of 3D compressed collagen constructs of HNSCC growth up to 10 d in lower (A) and higher magnification (B).
Scale bar represents 200 mm (A) and 100 mm (B). Blue colour indicates DAPI nucleus staining. Green colour indicates phalloidin filamentous actin staining.
Fig. 5 Dark toxicity and phototoxicities of Au NRs, PAA-Au NRs, PAA-Au NRs, PAA-Au NRs + TMPyP NRs and free TMPyP on 3D compressed collagen
constructs of HCSCC measured by Alamar Blue assay. The constructs were incubated with the samples at 20 mg mL1 Au NRs and the equivalent free
TMPyP concentration of PAA-Au NRs + TMPyP NRs. (A) Dark toxicities at 48 h incubation. (B) Cell viability under light illumination with a blue
LumiSources flatbed lamp at 420 nm and 7 mW cm2 output for 7 min and (C) 20 min at 24 h incubation and additional 24 h incubation post illumination.
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consisting of collagen (type 1) are ideal models to evaluate
the biological effects of drugs and biomaterials, mimicking
tumour growth within its local environment and characteristics
happening in vivo.80 Here, to test the dark toxicity and photo-
toxicity of the prepared photosensitizer loaded Au NRs, we
developed 3D compressed collagen constructs of HNSCC. First,
we monitored the cancer growth in the constructs up to 10 d at
certain time points, such as the 1st, 3rd, 7th and 10th day. To
visualize the cells in the construct, we stained them with the
DAPI nucleic dye and phalloidin filamentous actin dye. As can
be seen in Fig. 4, the images demonstrate that the cells
represent very well the growing profile in the construct and
start to form small spheroids even at short times. Based on
these results, we decided to use the earliest model of 3D
compressed collagen constructs growth for 1 d.
To understand the dark toxicity and phototoxicity of Au NRs,
PAA-Au NRs, PAA-Au NRs + TMPyP NRs and free TMPyP on
3D compressed collagen constructs, the samples were first
introduced to the constructs and incubated for 24 h. Then,
the media were refreshed and the 3D constructs were exposed
to light illumination for 7 min and 20 min for photodynamic
therapy or remained without illumination to assess the dark
toxicity of the samples. Fig. 5 shows that Au NRs exhibit high
dark toxicity, as shown in the 2D dark toxicity data in Fig. 2A.
However after PAA coating, the dark toxicity is abrogated and
the cell viability increase is comparable to that observed for
Fig. 6 Fluorescence microscopy images of 3D compressed collagen constructs of HNSCC. Untreated control constructs (A)–(C) and treated constructs
with PAA-Au NRs (D)–(F) and PAA-Au NRs + TMPyP NRs (G)–(I) at 20 mg mL1 Au NR concentration. Free TMPyP at the equivalent concentration (J)–(L).
Blue colour indicates DAPI nucleus staining. Red colour originates from TMPyP emission. Scale bar is 100 mm.
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controls that were not incubated with the NRs. Free TMPyP and
TMPyP loaded PAA-Au NRs exhibit high cell viability when no
light illumination was applied. In the case of light illumination
for 7 min, the cell viability of PAA-Au NRs and PAA-Au NRs +
TMPyP decreased slightly as compared to free TMPyP. When
the illumination time was longer, the phototoxicity of PAA-Au
NRs and PAA-Au NRs + TMPyP did not show any significant
change while the phototoxicity of TMPyP increased.
This could be explained by the limited diffusion of the Au
NRs within the 3D collagen microenvironment. Because of the
size of the Au NRs, which are larger than free TMPyP, they have
a slower diffusion rate, and the photodynamic effects of the
structures are limited in the 3D cancer environment.32
3.5 Fluorescence imaging of 3D constructs using cationic
porphyrin loaded Au NRs
The fluorescence images of 3D compressed collagen constructs
of HNSCC treated with samples for 24 h were recorded using an
inverted fluorescence microscope using filter sets for DAPI
nucleic staining and Cy5 for TMPyP. Due to the high toxicity
of the Au NRs, in this case, we used only PAA-Au NRs, PAA-Au
NRs + TMPyP and free TMPyP at equivalent concentrations. The
experiments were repeated with 2D monolayer structures,
however the signal intensity was too low to obtain clear images
(data not shown). The images shown in Fig. 6 clearly represent
the enhanced fluorescence intensity and efficient cell interna-
lization of TMPyP after being loaded with PAA-Au NRs, as seen
in Fig. 3, whereas PAA-Au NRs and control cells do not show any
emission. This strong synergistic effect between PAA-Au NRs
and TMPyP enables their application as an optical imaging
agent for cancer imaging as well as their photodynamic effects.
4. Conclusions
In this study, we synthesized Au NRs with an anionic polymer
coating and loaded them with a cationic porphyrin photo-
sensitizer, TMPyP, for photodynamic therapy and fluorescence
imaging of HNSCC in 2D and 3D in vitro cancer models.
We showed that coating the NRs with anionic PAA not only
conferred biocompatibility and low toxicity but also enabled
efficient loading of a cationic photosensitiser to form a nano-
composite delivery system. The results showed that the loading
of TMPyP to Au NRs enhances the absorbance and emission
intensity of the photosynthesizer and improves the ROS
generation by light irradiation under in vitro cell culture con-
ditions. For short-term illumination, TMPyP loaded NRs
showed significantly higher phototoxicity compared to free
photosensitizer at equivalent concentrations. Another impor-
tant result is that Au NRs are also themselves capable of
inducing a small degree of phototoxicity. In addition, 3D
compressed collagen constructs incubated with the samples
showed very strong fluorescence emission in the red region of
the optical spectrum with TMPyP incorporated Au NRs that
highlights the utility of 3D models as a biomimetic model for
in vivo conditions. The results show that Au NRs loaded with
TMPyP are promising agents for photodynamic therapy and
fluorescence imaging of HNSCC.
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